×
About 4,360 results

ALLMedicine™ Cutaneous Melanoma Center

Research & Reviews  1,634 results

Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients Wit...
https://doi.org/10.1001/jamanetworkopen.2021.26337
JAMA Network Open; Yang J, Lian JW et. al.

Sep 23rd, 2021 - Although tumor-infiltrating lymphocytes (TILs) are an important histopathologic characteristic reflecting host immune response in patients with melanoma, their prognostic value remains controversial. Because manual review of medical records is lab...

Regional variability of melanoma incidence and prevalence in Hungary. Epidemiological i...
https://doi.org/10.1097/CEJ.0000000000000716
European Journal of Cancer Prevention : the Official Jour... Janka EA, Ványai B et. al.

Sep 22nd, 2021 - The incidence of cutaneous melanoma has risen faster than almost any other type of cancer in the last 50 years. Ultraviolet (UV) radiation and genetic susceptibility are the most important risk factors. We aimed to determine the epidemiologic indi...

Plantar Melanoma: An Investigation of Its Incidence.
https://doi.org/10.1016/j.cpm.2021.06.012
Clinics in Podiatric Medicine and Surgery; An M, Blekher L et. al.

Sep 21st, 2021 - Melanoma accounts for more than 100,000 new cancer cases each year, and a minority (3%-15%) involve the foot and ankle. Case studies and isolated data set analyses report infrequent plantar melanomas, with these tumors more commonly encountered in...

Comparison of Survival Outcomes With/Without Adjuvant Radiation Therapy in Desmoplastic...
https://doi.org/10.1097/DSS.0000000000003177
Dermatologic Surgery : Official Publication for American ... Lewis GD, Guzman AK et. al.

Sep 20th, 2021 - Desmoplastic melanoma (DM) is a rare variant of cutaneous melanoma with a high rate of local recurrence. Recent studies have indicated a potential benefit in local control with the addition of adjuvant radiotherapy (RT). This study sought to evalu...

Cutaneous Melanoma More Likely to Be Invasive in Fairer Skin Phototypes: A Retrospectiv...
https://www.ncbi.nlm.nih.gov/pubmed/34526202
Skinmed Mercieca L, Aquilina S et. al.

Sep 17th, 2021 - Fitzpatrick skin phototype is one of the factors determining melanoma development, with fairer skin phototypes I and II known to be associated with a higher risk. This study aimed to identify any associations between skin phototype and the histolo...

see more →

Guidelines  8 results

SEOM clinical guideline for the management of cutaneous melanoma (2020).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998
Clinical & Translational Oncology : Official Publication ... Majem M, Manzano JL et. al.

Mar 3rd, 2021 - Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of t...

Systemic Therapy for Melanoma: ASCO Guideline.
https://doi.org/10.1200/JCO.20.00198
Journal of Clinical Oncology : Official Journal of the Am... Seth R, Messersmith H et. al.

Apr 2nd, 2020 - To provide guidance to clinicians regarding the use of systemic therapy for melanoma. ASCO convened an Expert Panel and conducted a systematic review of the literature. A systematic review, one meta-analysis, and 34 additional randomized trials we...

Guidelines of care for the management of primary cutaneous melanoma.
https://doi.org/10.1016/j.jaad.2018.08.055
Journal of the American Academy of Dermatology; Swetter SM, Tsao H et. al.

Nov 6th, 2018 - The incidence of primary cutaneous melanoma continues to increase each year. Melanoma accounts for the majority of skin cancer-related deaths, but treatment is usually curative following early detection of disease. In this American Academy of Derm...

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immun...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977556
Journal for Immunotherapy of Cancer; Sullivan RJ, Atkins MB et. al.

Jun 1st, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien...

New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distan...
https://doi.org/10.6004/jnccn.2018.0042
Journal of the National Comprehensive Cancer Network : JN... Barker CA, Salama AK

May 23rd, 2018 - The NCCN Guidelines Panel for Melanoma debuted new guidelines for uveal melanoma at the NCCN 23rd Annual Conference. Although uveal melanoma and cutaneous melanoma share the same name, they do have different characteristics and treatments. The NCC...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  1 results

Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma
https://clinicaltrials.gov/ct2/show/NCT03427398

Jan 31st, 2018 - PRIMARY OBJECTIVES: I. Estimate rate of objective response (OR: complete response [CR] + partial response [PR]) to ibrutinib administered as single agent in patients with immune checkpoint inhibitor-refractory and mitogen-activated protein kinase ...

see more →

News  100 results

Recent Trend: Melanoma Mortality Declining Rapidly
https://www.medscape.com/viewarticle/955112

Jul 20th, 2021 - Declining trends in melanoma death rates accelerated from 2014 to 2018 in the United States, even as incidence rates increased for both males and females, according to an annual report by several national organizations. "Death rates for cutaneous ...

UV Exposure Likely Not a Melanoma Risk for People of Color
https://www.medscape.com/viewarticle/943086

Dec 23rd, 2020 - NEW YORK (Reuters Health) - The association between ultraviolet (UV) exposure and melanoma is "weak" for skin of color, according to a new systematic review. "I was not surprised to find little to no evidence supporting the association between UV ...

What Happened to Melanoma Care During COVID-19 Sequestration
https://www.medscape.com/viewarticle/940924

Nov 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Initial evidence suggests that the deliberate delays in melanoma care that occurred during the COVID-19 shelter-in-place lockdown last spring had ...

Mohs Surgery May Not Boost Survival Over Standard Excision of Melanomas on Trunk, Extremities
https://www.medscape.com/viewarticle/940003

Oct 30th, 2020 - NEW YORK (Reuters Health) - Compared with wide local excision (WLE), Mohs micrographic surgery (MMS) does not appear to increase overall survival in patients with trunk or extremity melanomas, according to a retrospective study. "In contrast to ou...

Melanoma Patients Still at Higher Risk for New Malignancy After Successful Systemic Immunotherapy
https://www.medscape.com/viewarticle/938007

Sep 25th, 2020 - NEW YORK (Reuters Health) - Patients successfully treated for metastatic melanoma with immune-checkpoint inhibitors remain at increased risk for developing new primary cutaneous melanoma, according to a new study. "The 5-year risk was nearly 5%," ...

see more →